Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management
SINGAPORE, March 14, 2023 /PRNewswire/ -- Qritive, a leading developer of artificial intelligence (AI)-powered cancer diagnostics, and, Corista, a leading provider of clinical, research and educational digital pathology image management solutions, are announcing a new partnership in digital pathology. Through the partnership, Qritive's artificial intelligence modules and Corista's DP3® image management platform will be integrated to help pathologist's focus their...
Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy
SHANGHAI, March 14, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") reported positive topline results from the global, randomized, double-blind, placebo-controlled Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary IgA nephropathy (IgAN). The...
AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy’s Disease Treatment
TAIPEI, March 14, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel for spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's Disease. Under the terms of the license...
Telix’s ZIRCON Phase III Kidney Cancer Imaging Study Presented in “Game Changing” Session at EAU
MELBOURNE, Australia, March 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118).1 The results were featured in a "Game Changing" oral session delivered...
Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar
International partnership will see sensor installations in senior care facilities in all of Austco's operating regions, including Australia, the UK, Canada, and the US. DALLAS and TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Austco, an international manufacturer of nurse call systems and healthcare communications solutions for hospitals and senior care facilities, has partnered with Vayyar, the global leader...
Ping An Health achieves enhancement in managed care healthcare
Cumulative paying users continue to increase Gross margin increased significantly to 27.3% HONG KONG and SHANGHAI, March 13, 2023 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK) announced its 2022 annual results. The Company is committed to bridging doctors and patients with professionalism and safeguard everyone's health. With...
Annabella – the first breast pump to simulate a baby’s tongue, was launched in Israel, taking an estimated 10% of the monthly Israeli breast pump market, in February. The...
TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Annabella, the world's first breast pump to simulate a baby's tongue during the pumping process, was recently launched in Israel after five years of development. The Annabella made its market debut on February 16, 2023, and quickly captured an estimated 10% share of the monthly sales in the Israeli breast pump...
Apollo Hospitals Group Completes 500 Pediatric Liver Transplants
A historic milestone, The Apollo Liver Transplant Program has a success rate of over 90% in pediatric liver transplantation Apollo Hospitals Delhi performed India's first successful pediatric liver transplant in 1998 The 500th child weighed only 4.6kg at the time of the transplant NEW DELHI, March 13, 2023...
Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech’s Aflibercept Intravitreous Injection in China
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) in China. This is an investigational ophthalmic drug developed by the group's subsidiary Boan Biotech. The clinical study is being conducted by Boan Biotech...
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors
SUZHOU, China, March 13, 2023 /PRNewswire/ -- On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a strategic partnership to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-cell therapies for tumors and autoimmune diseases. Porton Advanced and Bennu Biotherapeutics...
